MarketCap
OncoSec Medical Incorporated ONCS
Facebook
X
Telegram
OncoSec Medical Incorporated ROCE | ONCS
ROCE Jährlich OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -604.93 | -127.06 | -214.63 | -122.08 | -147.99 | -182.67 | -19.36 | -21.52 | -10.67 | -41.96 | -36.95 | 196.04 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 196.04 | -604.93 | -111.15 |
ROCE Vierteljährlich OncoSec Medical Incorporated
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 765.64 | 578.44 | -198.24 | -173.62 | -126.89 | -102.27 | -148.16 | -551.21 | -574.51 | -977.55 | -961.54 | -569.96 | -557.3 | -165.72 | -131.18 | -142.75 | -138.52 | -150.09 | -164.09 | -145.7 | -154.42 | -138.41 | -119.71 | -116.76 | -105.69 | -100.36 | -98.25 | -88.44 | -85.5 | -75.68 | -64.44 | -63.42 | -55.86 | -54.83 | -56.18 | -62.35 | -73.59 | -79.75 | -141.06 | -63.25 | -63.81 | 14.0 | -117.22 | -380.71 | -353.07 | -360.44 | -154.83 | -205.61 | 0.29 | 50.5 |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 765.64 | -977.55 | -160.08 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Edesa Biotech
EDSA
|
-63.54 | $ 2.01 | -19.28 % | $ 11.4 M |  USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 15.12 | -0.72 % | $ 978 M | USA |
 |
Achieve Life Sciences
ACHV
|
-90.77 | $ 6.78 | 0.89 % | $ 296 M | USA |
 |
Fulcrum Therapeutics
FULC
|
-24.29 | $ 3.72 | -0.13 % | $ 236 M | USA |
 |
Immutep Limited
IMMP
|
-29.25 | $ 3.53 | -7.11 % | $ 5.14 B |  Australia |
 |
Iovance Biotherapeutics
IOVA
|
-52.06 | $ 8.09 | -1.04 % | $ 2.89 M | USA |
 |
Evogene Ltd.
EVGN
|
-84.53 | $ 0.37 | 28.7 % | $ 2.91 M |  Israel |
 |
Armata Pharmaceuticals
ARMP
|
16.76 | $ 3.71 | -2.5 % | $ 134 M | USA |
 |
Axsome Therapeutics
AXSM
|
-53.63 | $ 141.12 | 5.34 % | $ 7.02 B | USA |
 |
Keros Therapeutics
KROS
|
21.27 | $ 9.32 | 1.64 % | $ 347 M | USA |
 |
Champions Oncology
CSBR
|
-28.94 | $ 4.85 | 0.21 % | $ 67.1 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
-10.46 | $ 10.6 | -2.12 % | $ 303 M | USA |
|
Forte Biosciences
FBRX
|
-115.85 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Immunic
IMUX
|
1572.16 | $ 8.06 | 1.26 % | $ 1.25 B | USA |
 |
DiaMedica Therapeutics
DMAC
|
-61.16 | $ 9.7 | 0.47 % | $ 456 M | USA |
 |
Grifols, S.A.
GRFS
|
6.19 | $ 8.74 | 0.63 % | $ 5.94 B |  Spain |
 |
Incyte Corporation
INCY
|
27.83 | $ 120.28 | -1.32 % | $ 23.5 B | USA |
 |
AC Immune SA
ACIU
|
-116.39 | $ 2.32 | -4.92 % | $ 234 M |  Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
-79.69 | $ 0.64 | 0.53 % | $ 38.4 M | USA |
 |
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Precision BioSciences
DTIL
|
-35.84 | $ 9.47 | -2.17 % | $ 121 M | USA |
 |
AIM ImmunoTech
AIM
|
119.23 | $ 0.14 | -11.15 % | $ 227 K | USA |
 |
Ascendis Pharma A/S
ASND
|
-58.44 | $ 256.21 | -1.4 % | $ 15.5 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
9.56 | $ 71.31 | 5.19 % | $ 1.43 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
-462.69 | $ 1.56 | 1.3 % | $ 48.7 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-52.47 | $ 1.31 | -0.76 % | $ 349 M |  Britain |
|
Monopar Therapeutics
MNPR
|
-12.12 | $ 71.42 | -3.16 % | $ 529 M | USA |
 |
BridgeBio Pharma
BBIO
|
-82.04 | $ 78.67 | 0.95 % | $ 15.1 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
107.2 | $ 7.53 | -1.38 % | $ 1.58 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-37.4 | $ 3.68 | -2.39 % | $ 255 M | Britain |
 |
Coherus BioSciences
CHRS
|
-153.56 | $ 0.64 | -21.66 % | $ 75 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-4.03 | $ 27.45 | 4.77 % | $ 3.49 B | USA |
 |
Cellectis S.A.
CLLS
|
-18.48 | $ 1.12 | -0.45 % | $ 112 M |  France |
 |
BeyondSpring
BYSI
|
-213.69 | $ 0.6 | -2.21 % | $ 24.7 M | USA |
 |
Alkermes plc
ALKS
|
13.07 | $ 46.48 | 0.67 % | $ 7.66 B |  Irlanda |
 |
Altimmune
ALT
|
-42.02 | $ 1.94 | -8.51 % | $ 171 M | USA |
 |
Cardiff Oncology
CRDF
|
-107.87 | $ 0.79 | -0.77 % | $ 52.8 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
-57.03 | $ 0.5 | -5.43 % | $ 5.53 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-32.48 | $ 9.41 | -0.84 % | $ 258 M | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
8.53 | $ 49.04 | -0.41 % | $ 6.56 B | USA |
 |
Atara Biotherapeutics
ATRA
|
674.99 | $ 8.18 | -0.73 % | $ 103 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
5.72 | $ 16.3 | -1.93 % | $ 2.19 B | Canada |
 |
Cullinan Management
CGEM
|
-58.85 | $ 11.34 | -3.32 % | $ 683 M | USA |
 |
BioNTech SE
BNTX
|
-7.08 | $ 87.2 | -0.36 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
4.99 | $ 24.47 | -0.97 % | $ 775 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-57.84 | $ 3.95 | 12.07 % | $ 52.6 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.65 | $ 1.21 | -11.68 % | $ 55.3 M | Israel |
 |
AnaptysBio
ANAB
|
305.36 | $ 48.4 | 0.9 % | $ 1.4 B | USA |
 |
Assembly Biosciences
ASMB
|
-5.86 | $ 21.33 | -2.11 % | $ 239 M | USA |
 |
Adagene
ADAG
|
-58.67 | $ 2.02 | -4.95 % | $ 119 M |  China |